Juergen T.
- Country
- Germany
- Department
- Frauenheilkunde
Research Overview
- CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
- Phase III Randomized, Double-Blind Trial of Atezolizumab with Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
- Phase 3 Randomized Study of GLSI-100 (GP2 + Sargramostim) in HER2/neu Positive Breast Cancer with Residual Disease or High-Risk PCR Post-Trastuzumab Therapy
Data & Insights
Has run more than one trial at 264 of 627 partner sites.
Specializations
Breast Cancer Immunotherapy
Specializes in investigating immunotherapeutic approaches for breast cancer treatment, with particular emphasis on HER2-positive breast cancer and novel peptide-based therapies targeting residual disease.
- HER2/neu peptide treatments
- Post-neoadjuvant therapy strategies
- Triple-negative breast cancer interventions
Focuses on therapeutic solutions for patients with high risk of disease recurrence following standard treatments.
Hormone Receptor-Positive Breast Cancer
Conducts research in endocrine therapy optimization and targeted treatments for hormone receptor-positive breast cancer, particularly exploring novel therapeutic combinations.
- Advanced endocrine therapy approaches
- CDK4/6 inhibitor applications
- Early-stage breast cancer interventions
Explores innovative treatment strategies for both early-stage and advanced breast cancer patients.
Precision Medicine in Oncology
Investigates molecular patterns and therapeutic resistance mechanisms in breast cancer, with special attention to biomarker-driven treatment approaches.
- Spatial-temporal analysis of treatment response
- Molecular profiling strategies
- Personalized treatment protocols
Develops comprehensive analytical approaches to understand and overcome treatment resistance in breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.